瑞普生物公告，第五届董事会第二十五次（临时）会议于2025年8月8日召开，审议通过《关于公司及子公司继续开展资产池业务并提供担保的议案》，同意总额不超过1亿元的资产池业务，有效期一年，涉及公司及部分分子公司与 浙商银行 天津分行的合作。同时，会议决定于2025年8月25日召开第四次临时股东大会审议该议案。本次担保事项符合监管要求，财务风险可控，有利于公司长远发展。
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.